CannaPharmaRx (OTC: CPMD) is positioned to become a future leader in ultra-modern, highly efficient cannabis production facilities in Canada.
CannaPharmaRx, Inc. is focused on the acquisition and development of state-of-the-art cannabis grow facilities located in Canada.
The company owns a 48,500-square-foot cannabis grow facility presently under development and is currently in discussion with other companies regarding potential acquisitions.
CPMD’s business strategy is to become a leader in high-quality and low-cost production of cannabis through the development, acquisition and enhancement of existing facilities.
The company is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.
"While there has been a fundamental shift in the way many businesses are forced to operate due to these unprecedented circumstances, the need to produce high quality, pharmaceutical-grade medical cannabis in ultra-modern, highly efficient facilities remains constant. We are firmly committed to our unique business model," said Nick Colvin of CannaPharmaRx, Inc.